Cytokinetics Inc. buy Royal Bank of Canada
Start price
07.05.25
/
50%
€29.40
Target price
07.05.26
€70.52
Performance (%)
112.86%
End price
08.05.26
€62.58
Summary
This prediction ended on 08.05.26 with a price of €62.58. The BUY prediction by Royal_Bank_of_Canada for Cytokinetics Inc. saw massive gains of 112.86%. Royal_Bank_of_Canada has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 5.079% | 5.079% | 153.521% |
| iShares Core DAX® | -1.358% | -2.165% | 2.078% |
| iShares Nasdaq 100 | -3.700% | -1.162% | 32.596% |
| iShares Nikkei 225® | -2.512% | 7.930% | 58.269% |
| iShares S&P 500 | -1.662% | -0.698% | 22.962% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Royal Bank of Canada from $82.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25
